These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10195340)

  • 1. Application of a new statistical approach to evaluate a clinical trial with panic disorder patients.
    Bandelow B; Brunner E; Beinroth D; Pralle L; Broocks A; Hajak G; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):21-7. PubMed ID: 10195340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the Panic and Agoraphobia Scale in a clinical trial.
    Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E
    Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems.
    Bandelow B; Hajak G; Holzrichter S; Kunert HJ; Rüther E
    Int Clin Psychopharmacol; 1995 Jun; 10(2):83-93. PubMed ID: 7673660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.
    Bandelow B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):73-81. PubMed ID: 7673659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine for vestibular dysfunction in panic disorder: a prospective case series.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
    Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
    Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine treatment of panic disorder with agoraphobia: the second time around.
    Mavissakalian MR; Perel JM; de Groot C
    J Psychiatr Res; 1993; 27(1):61-8. PubMed ID: 8515390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
    Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the severity of panic disorder and agoraphobia: validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A).
    Tural U; Fidane H; Alkin T; Bandelow B
    J Anxiety Disord; 2002; 16(3):331-40. PubMed ID: 12214818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ; Endler NS; Lee PS; Swinson RP
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
    Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
    J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan.
    Ogawa S; Kondo M; Ino K; Ii T; Imai R; Furukawa TA; Akechi T
    East Asian Arch Psychiatry; 2017 Dec; 27(4):150-5. PubMed ID: 29259145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia.
    Salkovskis PM; Clark DM; Hackmann A; Wells A; Gelder MG
    Behav Res Ther; 1999 Jun; 37(6):559-74. PubMed ID: 10372469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scores of Hamilton depression, anxiety, and panic agoraphobia rating scales in patients with acute coronary syndrome.
    Vural M; Acer M; Akbaş B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):43-7. PubMed ID: 18258533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.
    Furukawa TA; Katherine Shear M; Barlow DH; Gorman JM; Woods SW; Money R; Etschel E; Engel RR; Leucht S
    Depress Anxiety; 2009; 26(10):922-9. PubMed ID: 19006198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.